Literature DB >> 24574186

Chloral hydrate sedation for infant pulmonary function testing.

Clement L Ren1, Paul Robinson, Sarath Ranganathan.   

Abstract

Entities:  

Mesh：

Year:  2014        PMID： 24574186      PMCID： PMC4143482          DOI： 10.1002/ppul.23012

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN： 1099-0496


× No keyword cloud information.
  10 in total

1.  Forced expiratory flows and volumes in infants. Normative data and lung growth.

Authors:  M Jones; R Castile; S Davis; J Kisling; D Filbrun; R Flucke; A Goldstein; C Emsley; W Ambrosius; R S Tepper
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

2.  Need for healthy control subjects when assessing lung function in infants with respiratory disease.

Authors:  Janet Stocks; Neena Modi; Robert Tepper
Journal:  Am J Respir Crit Care Med       Date:  2010-12-01       Impact factor: 21.405

3.  Sedation in infant pulmonary function testing.

Authors:  Satyanarayan Hegde
Journal:  Pediatr Pulmonol       Date:  2013-06-24

4.  Multicenter evaluation of infant lung function tests as cystic fibrosis clinical trial endpoints.

Authors:  Stephanie D Davis; Margaret Rosenfeld; Gwendolyn S Kerby; Lyndia Brumback; Margaret H Kloster; James D Acton; Andrew A Colin; Carol K Conrad; Meeghan A Hart; Peter W Hiatt; Peter J Mogayzel; Robin C Johnson; Stephanie L Wilcox; Robert G Castile
Journal:  Am J Respir Crit Care Med       Date:  2010-07-09       Impact factor: 21.405

5.  Chloral hydrate sedation in neonates and infants--clinical and pharmacologic considerations.

Authors:  L D Reimche; K Sankaran; K W Hindmarsh; G F Kasian; D K Gorecki; L Tan
Journal:  Dev Pharmacol Ther       Date:  1989

6.  Respiratory function measurements in infants: measurement conditions. Working Group of the European Respiratory Society and the American Thoracic Society.

Authors:  C Gaultier; M E Fletcher; C Beardsmore; S England; E Motoyama
Journal:  Eur Respir J       Date:  1995-06       Impact factor: 16.671

7.  American Academy of Pediatrics Committee on Drugs and Committee on Environmental Health: Use of chloral hydrate for sedation in children.

Authors: 
Journal:  Pediatrics       Date:  1993-09       Impact factor: 7.124

8.  Inhaled hypertonic saline in infants and children younger than 6 years with cystic fibrosis: the ISIS randomized controlled trial.

Authors:  Margaret Rosenfeld; Felix Ratjen; Lyndia Brumback; Stephen Daniel; Ron Rowbotham; Sharon McNamara; Robin Johnson; Richard Kronmal; Stephanie D Davis
Journal:  JAMA       Date:  2012-06-06       Impact factor: 56.272

9.  Lung function in infants with cystic fibrosis diagnosed by newborn screening.

Authors:  Barry M Linnane; Graham L Hall; Gary Nolan; Siobhan Brennan; Stephen M Stick; Peter D Sly; Colin F Robertson; Philip J Robinson; Peter J Franklin; Stephen W Turner; Sarath C Ranganathan
Journal:  Am J Respir Crit Care Med       Date:  2008-09-11       Impact factor: 21.405

10.  Lung function is abnormal in 3-month-old infants with cystic fibrosis diagnosed by newborn screening.

Authors:  Ah-Fong Hoo; Lena P Thia; The Thanh Diem Nguyen; Andrew Bush; Jane Chudleigh; Sooky Lum; Deeba Ahmed; Ian Balfour Lynn; Siobhan B Carr; Richard J Chavasse; Kate L Costeloe; John Price; Anu Shankar; Colin Wallis; Hilary A Wyatt; Angela Wade; Janet Stocks
Journal:  Thorax       Date:  2012-06-29       Impact factor: 9.139
  10 in total
  4 in total

1.  Reference values for resistance and compliance based on the single occlusion technique in healthy infants from Southeast China.

Authors:  Jianfeng Huang; Hao Zhang; Mingzhi Zhang; Xiaobo Zhang; Libo Wang
Journal:  J Thorac Dis       Date:  2016-03       Impact factor: 2.895

2.  Early Neonatal Oxygen Exposure Predicts Pulmonary Morbidity and Functional Deficits at 1 Year.

Authors:  Andrew M Dylag; Hannah G Kopin; Michael A O'Reilly; Hongyue Wang; Stephanie D Davis; Clement L Ren; Gloria S Pryhuber
Journal:  J Pediatr       Date:  2020-08       Impact factor: 6.314

3.  Low cord-serum 25-hydroxyvitamin D levels are associated with poor lung function performance and increased respiratory infection in infancy.

Authors:  Shen-Hao Lai; Sui-Ling Liao; Ming-Han Tsai; Man-Chin Hua; Chih-Yung Chiu; Kuo-Wei Yeh; Tsung-Chieh Yao; Jing-Long Huang
Journal:  PLoS One       Date:  2017-03-07       Impact factor: 3.240

4.  Efficacy and safety of chloral hydrate sedation in infants for pulmonary function tests.

Authors:  Gustavo Falbo Wandalsen; Fernanda de Cordoba Lanza; Márcia Cristina Pires Nogueira; Dirceu Solé
Journal:  Rev Paul Pediatr       Date:  2016-06-22
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.